Bioinformatics driven personalized medicine: integrating multi-omics intelligence for precision therapeutics

Radha S

doi:10.70604/

Authors

S.Radha Lecturer in Botany, Govt. Degree College, Rajam, Vizianagaram (Dist)

Abstract

The integration of bioinformatics and multi-omics technologies has revolutionized personalized medicine, enabling data-driven precision therapeutics. By combining genomic, transcriptomic, proteomic, metabolomic, and epigenomic insights, bioinformatics decodes complex biological networks and uncovers molecular signatures that predict disease progression, drug response, and resistance mechanisms. Advanced computational methods, including machine learning and artificial intelligence, enhance data integration and patient stratification, transforming heterogeneous datasets into actionable clinical intelligence. Applications span oncology, pharmacogenomics, immunology, and rare diseases, offering targeted, individualized therapies. Despite progress, challenges such as data harmonization, interoperability, and ethical governance persist. Emerging frontiers-including single-cell and spatial omics, digital twins, and quantum-enhanced AI-promise to refine predictive modeling and accelerate translational medicine. The synergy of computational innovation and clinical insight heralds a paradigm shift from reactive treatment to proactive, adaptive healthcare, ensuring a more precise and equitable future for global medicine.

Keywords:

Bioinformatics, Multi-Omics Integration, Precision Therapeutics, Artificial Intelligence, Personalized Medicine, Systems Biology

DOI

https://doi.org/10.70604/

References

1. Chen R, Snyder M. Systems biology: Personalized medicine for the future? Mol Syst Biol. 2012;8:642.

2. Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):83.

3. Karczewski KJ, Snyder MP. Integrative omics for health and disease. Nat Rev Genet. 2018;19(5):299-310.

4. Argelaguet R, Velten B, Arnol D. Multi-Omics Factor Analysis (MOFA) for unsupervised integration of multi-omics data sets. Mol Syst Biol. 2018;14(6):e8124.

5. Wang B, Mezlini AM, Demir F. Similarity network fusion for aggregating data types on a genomic scale. Nat Methods. 2014;11(3):333-7.

6. Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929-35.

7. Subramanian A, Narayan R, Corsello SM, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437-1452.e17.

8. Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607-D613.

9. Howe KL, Achuthan P, Allen J. Ensembl 2021. Nucleic Acids Res. 2021;49(D1):D884-D891.

10. Assenov Y, Ramirez F, Schelhorn S-E, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282-4.

11. Tokar T, Pastrello C, Rossos AEM, et al. mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res. 2018;46(D1):D360-D370.

12. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018.

13. Global Alliance for Genomics and Health. A federated ecosystem for sharing genomic and clinical data. Science. 2016;352(6288):1278-80.

14. Eraslan G, Avsec Ž, Gagneur J, Theis FJ. Deep learning: new computational modelling techniques for genomics. Nat Rev Genet. 2019;20(7):389-403.

15. Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30:4765-4774.

16. Ribeiro MT, Singh S, Guestrin C. “Why should I trust you?”: Explaining the predictions of any classifier. Proc. 22nd ACM SIGKDD Int. Conf. Knowledge Discovery & Data Mining. 2016;1135-1144.

17. Li T, Sahu AK, Talwalkar A, Smith V. Federated learning: challenges, methods, and future directions. IEEE Signal Process Mag. 2020;37(3):50-60.

18. Ståhl PL, Salmén F, Vickovic S. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353(6294):78-82.

19. Regev A, Teichmann SA, Lander ES, et al. The Human Cell Atlas. eLife. 2017;6:e27041.

20. Mani S, Jain S, Vedam V, et al. Genomics and multi-omics in the age of precision medicine. Pediatr Res. 2025; (in press).

21. Molla G, Islam R, Tasnim Z, et al. Revolutionizing Personalized Medicine: Synergy with Multi-Omics and Artificial Intelligence. Biomedicines. 2024;12(4):800.

22. Coskun A, et al. Advancing personalized medicine: Integrating statistical and multi-omics approaches. J Lab Precis Med. 2024;9:18.

23. Styczynski MP, Jensen H, Rigoutsos I, et al. Navigating Challenges and Opportunities in Multi-Omics Integration and Translation to Healthcare. Biomolecules. 2022;12(7):1496.

24. Tan AC, Greer SU, Kapur K. Integrative Multi-Omics and Artificial Intelligence: A review on current approaches and future directions. SAGE Open Med. 2025;13:20503121251239271.

25. Kinker GS, Greenwald AC, Tal R, et al. Pan-cancer single-cell RNA-seq reveals recurrent programmes of cellular heterogeneity. Nature. 2020;578(7793):148-153.

26. Grizzi F, Zanetti E. Rare diseases, multimodal omics and machine learning: A new frontier for personalized medicine. Front Mol Biosci. 2023;10:936790.

27. Ferro A, Galdà G, Commodaro G, et al. Multi-omics integration for precision therapeutics: translational challenges and perspectives. Mol Oncol. 2021;15(9):2290-2309.

28. Liu Y, Cheng H, Jiang S, et al. Digital twin and in silico therapeutics: Transforming precision medicine with computational modeling. Med Image Anal. 2024;84:102786.

29. Liu X, Zhang C, Zhang Z, et al. Real-world data integration: merging EHR, imaging, wearables and omics toward personalized health. NPJ Digit Med. 2023;6:154.

30. Negi S, Kumar A, Kumar V. The rise of single-cell and spatial omics in personalized medicine. Trends Genet. 2024;40(5):398-412.